Related Articles for PubMed (Select 18522728)

Expression of the epidermal growth factor receptor (EGFR) and the phosphorylated EGFR in invasive breast carcinomas.

Magkou C, Nakopoulou L, Zoubouli C, Karali K, Theohari I, Bakarakos P, Giannopoulou I.

Breast Cancer Res. 2008;10(3):R49. Epub 2008 Jun 3.

PMID: 18522728 [PubMed - indexed for MEDLINE]

Clinicopathological and prognostic significance of vascular endothelial growth factors (VEGF)-C and -D and VEGF receptor 3 in invasive breast carcinoma.

Mylona E, Alexandrou P, Mpakali A, Giannopoulou I, Liapis G, Markaki S, Keramopoulos A, Nakopoulou L.

Eur J Surg Oncol. 2007 Apr;33(3):294-300. Epub 2006 Nov 28.

PMID: 17129704 [PubMed - indexed for MEDLINE]

Expression patterns and predictive value of phosphorylated AKT in early-stage breast cancer.

Andre F, Nahta R, Conforti R, Boulet T, Aziz M, Yuan LX, Meslin F, Spielmann M, Tomasic G, Pusztai L, Hortobagyi GN, Michiels S, Delaloge S, Esteva FJ.

Ann Oncol. 2008 Feb;19(2):315-20. Epub 2007 Sep 5.

PMID: 17804473 [PubMed - indexed for MEDLINE]

Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer.

Nakamura Y, Yasuoka H, Tsujimoto M, Yang Q, Imabun S, Nakahara M, Nakao K, Nakamura M, Mori I, Kakudo K.

Clin Cancer Res. 2003 Nov 1;9(14):5313-7.

PMID: 14614015 [PubMed - indexed for MEDLINE]

Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer.

Cappuzzo F, Hirsch FR, Rossi E, Bartolini S, Ceresoli GL, Bemis L, Haney J, Witta S, Danenberg K, Domenichini I, Ludovini V, Magrini E, Gregorc V, Doglioni C, Sidoni A, Tonato M, Franklin WA, Crino L, Bunn PA Jr, Varella-Garcia M.

J Natl Cancer Inst. 2005 May 4;97(9):643-55.

PMID: 15870435 [PubMed - indexed for MEDLINE]

Prognostic value of the type I growth factor receptors in a large series of human primary breast cancers quantified with a real-time reverse transcription-polymerase chain reaction assay.

Pawlowski V, Révillion F, Hebbar M, Hornez L, Peyrat JP.

Clin Cancer Res. 2000 Nov;6(11):4217-25.

PMID: 11106235 [PubMed - indexed for MEDLINE]

Study of the topographic distribution of ets-1 protein expression in invasive breast carcinomas in relation to tumor phenotype.

Mylona EE, Alexandrou PT, Giannopoulou IA, Rafailidis PI, Markaki S, Keramopoulos A, Nakopoulou LL.

Cancer Detect Prev. 2006;30(2):111-7. Epub 2006 May 2.

PMID: 16632244 [PubMed - indexed for MEDLINE]

Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer.

Leek RD, Hunt NC, Landers RJ, Lewis CE, Royds JA, Harris AL.

J Pathol. 2000 Mar;190(4):430-6.

PMID: 10699991 [PubMed - indexed for MEDLINE]

Matrix metalloproteinase 9 and the epidermal growth factor signal pathway in operable non-small cell lung cancer.

Cox G, Jones JL, O'Byrne KJ.

Clin Cancer Res. 2000 Jun;6(6):2349-55.

PMID: 10873086 [PubMed - indexed for MEDLINE]

10:

Expression of amphiregulin and epidermal growth factor receptor in human breast cancer: analysis of autocriny and stromal-epithelial interactions.

Ma L, de Roquancourt A, Bertheau P, Chevret S, Millot G, Sastre-Garau X, Espié M, Marty M, Janin A, Calvo F.

J Pathol. 2001 Aug;194(4):413-9.

PMID: 11523048 [PubMed - indexed for MEDLINE]

11:

Phosphorylation, but not overexpression, of epidermal growth factor receptor is associated with poor prognosis of non-small cell lung cancer patients.

Kanematsu T, Yano S, Uehara H, Bando Y, Sone S.

Oncol Res. 2003;13(5):289-98.

PMID: 12688680 [PubMed - indexed for MEDLINE]

12:

Upregulation of basic fibroblast growth factor in breast carcinoma and its relationship to vascular density, oestrogen receptor, epidermal growth factor receptor and survival.

Smith K, Fox SB, Whitehouse R, Taylor M, Greenall M, Clarke J, Harris AL.

Ann Oncol. 1999 Jun;10(6):707-13.

PMID: 10442194 [PubMed - indexed for MEDLINE]

13:

An immunohistochemical evaluation of phosphorylated Akt at threonine 308 [pAkt(Thr308)] in invasive breast cancer.

Magkou C, Mylona E, Theohari I, Giannopoulou I, Papanikolaou E, Markaki S, Nakopoulou L.

In Vivo. 2007 Nov-Dec;21(6):967-72.

PMID: 18210742 [PubMed - indexed for MEDLINE]

14:

Plasminogen activator inhibitor-1 as a measure of vascular remodelling in breast cancer.

Fox SB, Taylor M, Grøndahl-Hansen J, Kakolyris S, Gatter KC, Harris AL.

J Pathol. 2001 Sep;195(2):236-43.

PMID: 11592104 [PubMed - indexed for MEDLINE]

15:

Dual inhibition of epidermal growth factor receptor and vascular endothelial growth factor receptor phosphorylation by AEE788 reduces growth and metastasis of human colon carcinoma in an orthotopic nude mouse model.

Yokoi K, Thaker PH, Yazici S, Rebhun RR, Nam DH, He J, Kim SJ, Abbruzzese JL, Hamilton SR, Fidler IJ.

Cancer Res. 2005 May 1;65(9):3716-25.

PMID: 15867367 [PubMed - indexed for MEDLINE]

16:

Coexpression of epidermal growth factor receptor with related factors is associated with a poor prognosis in non-small-cell lung cancer.

Swinson DE, Cox G, O'Byrne KJ.

Br J Cancer. 2004 Oct 4;91(7):1301-7.

PMID: 15365565 [PubMed - indexed for MEDLINE]

17:

Prognostic significance of c-erbB-2/neu amplification and epidermal growth factor receptor (EGFR) in primary breast cancer and their relation to estradiol receptor (ER) status.

Torregrosa D, Bolufer P, Lluch A, López JA, Barragán E, Ruiz A, Guillem V, Munárriz B, García Conde J.

Clin Chim Acta. 1997 Jun 27;262(1-2):99-119.

PMID: 9204213 [PubMed - indexed for MEDLINE]

18:

Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis.

Pellikainen JM, Ropponen KM, Kataja VV, Kellokoski JK, Eskelinen MJ, Kosma VM.

Clin Cancer Res. 2004 Nov 15;10(22):7621-8.

PMID: 15569994 [PubMed - indexed for MEDLINE]

19:

Comparison of the prognosis indication of VEGFR-1 and VEGFR-2 and Tie2 receptor expression in breast carcinoma.

Meunier-Carpentier S, Dales JP, Djemli A, Garcia S, Bonnier P, Andrac-Meyer L, Lavaut MN, Allasia C, Charpin C.

Int J Oncol. 2005 Apr;26(4):977-84.

PMID: 15753992 [PubMed - indexed for MEDLINE]

20:

Human breast cancer: prognostic significance of the c-erbB-2 oncoprotein compared with epidermal growth factor receptor, DNA ploidy, and conventional pathologic features.

Gasparini G, Gullick WJ, Bevilacqua P, Sainsbury JR, Meli S, Boracchi P, Testolin A, La Malfa G, Pozza F.

J Clin Oncol. 1992 May;10(5):686-95.

PMID: 1349034 [PubMed - indexed for MEDLINE]

Recent Activity